Compounding Pharmacy Market (Pharmacy Type: 503A Pharmacies and 503B Pharmacies; Compounding Type: Pharmaceutical Ingredient Alteration (PIA), Drug Shortage Manufacturing, and Pharmaceutical Dosage Alteration (PDA); Sterility: Sterile and Non Sterile; Dos

Compounding Pharmacy Market – Scope of Report

TMR’s report on the global compounding pharmacy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global compounding pharmacy market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global compounding pharmacy market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the compounding pharmacy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global compounding pharmacy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global compounding pharmacy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global compounding pharmacy market.

The report delves into the competitive landscape of the global compounding pharmacy market. Key players operating in the global compounding pharmacy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global compounding pharmacy market profiled in this report.

Key Questions Answered in Global compounding pharmacy Market Report

  • What is the sales/revenue generated by compounding pharmacy across all regions during the forecast period?
  • What are the opportunities in the global compounding pharmacy market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Compounding Pharmacy Market – Research Objectives and Research Approach

The comprehensive report on the global compounding pharmacy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global compounding pharmacy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global compounding pharmacy market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Compounding Pharmacy Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Compounding Pharmacy Market Analysis and Forecasts, 2020-2034
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements that assist Pharmaceutical Compounding
5.2. Insights on In-house and Outsourced Pharmaceutical Compounding
5.3. Discussion on Benefits and Potential Risks of Pharmaceutical Compounding
5.4. List of Compounding Pharmacies across Key Region / Countries
5.5. Regulatory Scenario across Key Regions / Countries
5.6. PORTER’s Five Forces Analysis
5.7. PESTEL Analysis
5.8. Value Chain Analysis
5.9. Go-to-Market Strategy for New Market Entrants
5.10. Key Industry Events
6. Global Compounding Pharmacy Market Analysis and Forecasts, By Pharmacy Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Pharmacy Type, 2020-2034
6.3.1. 503A Pharmacies
6.3.2. 503B Pharmacies
6.4. Market Attractiveness By Pharmacy Type
7. Global Compounding Pharmacy Market Analysis and Forecasts, By Compounding Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Compounding Type, 2020-2034
7.3.1. Pharmaceutical Ingredient Alteration (PIA)
7.3.2. Drug Shortage Manufacturing
7.3.3. Pharmaceutical Dosage Alteration (PDA)
7.4. Market Attractiveness By Compounding Type
8. Global Compounding Pharmacy Market Analysis and Forecasts, By Sterility
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Sterility, 2020-2034
8.3.1. Sterile
8.3.2. Non-sterile
8.4. Market Attractiveness By Sterility
9. Global Compounding Pharmacy Market Analysis and Forecasts, By Dosage Form
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By Dosage Form, 2020-2034
9.3.1. Oral Medications
9.3.1.1. Capsules
9.3.1.2. Tablets
9.3.1.3. Suspensions
9.3.1.4. Others (Chewables, etc.)
9.3.2. Topical Medications
9.3.2.1. Creams
9.3.2.2. Gels
9.3.2.3. Ointments
9.3.2.4. Others (Paste, etc.)
9.3.3. Injectables
9.3.4. Suppositories
9.3.5. Others
9.4. Market Attractiveness By Dosage Form
10. Global Compounding Pharmacy Market Analysis and Forecasts, By Application
10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Market Value Forecast By Application, 2020-2034
10.3.1. Hormone Replacement Therapy
10.3.2. Pain Management
10.3.3. Neurology
10.3.4. Dermatology
10.3.5. Ophthalmology
10.3.6. Nutritional Supplements
10.3.7. Others (ENT, Thyroid Disorders, etc.)
10.4. Market Attractiveness By Application
11. Global Compounding Pharmacy Market Analysis and Forecasts, By Patient Demographics
11.1. Introduction & Definition
11.2. Key Findings / Developments
11.3. Market Value Forecast By Patient Demographics, 2020-2034
11.3.1. Human
11.3.1.1. Pediatric
11.3.1.2. Adult
11.3.1.3. Geriatric
11.3.2. Veterinary
11.4. Market Attractiveness By Patient Demographics
12. Global Compounding Pharmacy Market Analysis and Forecasts, By Region
12.1. Key Findings
12.2. Market Value Forecast By Region
12.2.1. North America
12.2.2. Europe
12.2.3. Asia Pacific
12.2.4. Latin America
12.2.5. Middle East & Africa
12.3. Market Attractiveness By Country/Region
13. North America Compounding Pharmacy Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Pharmacy Type, 2020-2034
13.2.1. 503A Pharmacies
13.2.2. 503B Pharmacies
13.3. Market Value Forecast By Compounding Type, 2020-2034
13.3.1. Pharmaceutical Ingredient Alteration (PIA)
13.3.2. Drug Shortage Manufacturing
13.3.3. Pharmaceutical Dosage Alteration (PDA)
13.4. Market Value Forecast By Sterility, 2020-2034
13.4.1. Sterile
13.4.2. Non-sterile
13.5. Market Value Forecast By Dosage Form, 2020-2034
13.5.1. Oral Medications
13.5.1.1. Capsules
13.5.1.2. Tablets
13.5.1.3. Suspensions
13.5.1.4. Others (Chewables, etc.)
13.5.2. Topical Medications
13.5.2.1. Creams
13.5.2.2. Gels
13.5.2.3. Ointments
13.5.2.4. Others (Paste, etc.)
13.5.3. Injectables
13.5.4. Suppositories
13.5.5. Others
13.6. Market Value Forecast By Application, 2020-2034
13.6.1. Hormone Replacement Therapy
13.6.2. Pain Management
13.6.3. Neurology
13.6.4. Dermatology
13.6.5. Ophthalmology
13.6.6. Nutritional Supplements
13.6.7. Others (ENT, Thyroid Disorders, etc.)
13.7. Market Value Forecast By Patient Demographics, 2020-2034
13.7.1. Human
13.7.1.1. Pediatric
13.7.1.2. Adult
13.7.1.3. Geriatric
13.7.2. Veterinary
13.8. Market Value Forecast By Country, 2020-2034
13.8.1. U.S.
13.8.2. Canada
13.9. Market Attractiveness Analysis
13.9.1. By Pharmacy Type
13.9.2. By Compounding Type
13.9.3. By Sterility
13.9.4. By Dosage Form
13.9.5. By Application
13.9.6. By Patient Demographics
13.9.7. By Country
14. Europe Compounding Pharmacy Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Pharmacy Type, 2020-2034
14.2.1. 503A Pharmacies
14.2.2. 503B Pharmacies
14.3. Market Value Forecast By Compounding Type, 2020-2034
14.3.1. Pharmaceutical Ingredient Alteration (PIA)
14.3.2. Drug Shortage Manufacturing
14.3.3. Pharmaceutical Dosage Alteration (PDA)
14.4. Market Value Forecast By Sterility, 2020-2034
14.4.1. Sterile
14.4.2. Non-sterile
14.5. Market Value Forecast By Dosage Form, 2020-2034
14.5.1. Oral Medications
14.5.1.1. Capsules
14.5.1.2. Tablets
14.5.1.3. Suspensions
14.5.1.4. Others (Chewables, etc.)
14.5.2. Topical Medications
14.5.2.1. Creams
14.5.2.2. Gels
14.5.2.3. Ointments
14.5.2.4. Others (Paste, etc.)
14.5.3. Injectables
14.5.4. Suppositories
14.5.5. Others
14.6. Market Value Forecast By Application, 2020-2034
14.6.1. Hormone Replacement Therapy
14.6.2. Pain Management
14.6.3. Neurology
14.6.4. Dermatology
14.6.5. Ophthalmology
14.6.6. Nutritional Supplements
14.6.7. Others (ENT, Thyroid Disorders, etc.)
14.7. Market Value Forecast By Patient Demographics, 2020-2034
14.7.1. Human
14.7.1.1. Pediatric
14.7.1.2. Adult
14.7.1.3. Geriatric
14.7.2. Veterinary
14.8. Market Value Forecast By Country/Sub-region, 2020-2034
14.8.1. Germany
14.8.2. U.K.
14.8.3. France
14.8.4. Italy
14.8.5. Spain
14.8.6. Rest of Europe
14.9. Market Attractiveness Analysis
14.9.1. By Pharmacy Type
14.9.2. By Compounding Type
14.9.3. By Sterility
14.9.4. By Dosage Form
14.9.5. By Application
14.9.6. By Patient Demographics
14.9.7. By Country/Sub-region
15. Asia Pacific Compounding Pharmacy Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Pharmacy Type, 2020-2034
15.2.1. 503A Pharmacies
15.2.2. 503B Pharmacies
15.3. Market Value Forecast By Compounding Type, 2020-2034
15.3.1. Pharmaceutical Ingredient Alteration (PIA)
15.3.2. Drug Shortage Manufacturing
15.3.3. Pharmaceutical Dosage Alteration (PDA)
15.4. Market Value Forecast By Sterility, 2020-2034
15.4.1. Sterile
15.4.2. Non-sterile
15.5. Market Value Forecast By Dosage Form, 2020-2034
15.5.1. Oral Medications
15.5.1.1. Capsules
15.5.1.2. Tablets
15.5.1.3. Suspensions
15.5.1.4. Others (Chewables, etc.)
15.5.2. Topical Medications
15.5.2.1. Creams
15.5.2.2. Gels
15.5.2.3. Ointments
15.5.2.4. Others (Paste, etc.)
15.5.3. Injectables
15.5.4. Suppositories
15.5.5. Others
15.6. Market Value Forecast By Application, 2020-2034
15.6.1. Hormone Replacement Therapy
15.6.2. Pain Management
15.6.3. Neurology
15.6.4. Dermatology
15.6.5. Ophthalmology
15.6.6. Sports Medicine
15.6.7. Nutritional Supplements
15.6.8. Others (ENT, Thyroid Disorders, etc.)
15.7. Market Value Forecast By Patient Demographics, 2020-2034
15.7.1. Human
15.7.1.1. Pediatric
15.7.1.2. Adult
15.7.1.3. Geriatric
15.7.2. Veterinary
15.8. Market Value Forecast By Country/Sub-region, 2020-2034
15.8.1. China
15.8.2. India
15.8.3. Japan
15.8.4. Australia & New Zealand
15.8.5. Rest of Asia Pacific
15.9. Market Attractiveness Analysis
15.9.1. By Pharmacy Type
15.9.2. By Compounding Type
15.9.3. By Sterility
15.9.4. By Dosage Form
15.9.5. By Application
15.9.6. By Patient Demographics
15.9.7. By Country/Sub-region
16. Latin America Compounding Pharmacy Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast By Pharmacy Type, 2020-2034
16.2.1. 503A Pharmacies
16.2.2. 503B Pharmacies
16.3. Market Value Forecast By Compounding Type, 2020-2034
16.3.1. Pharmaceutical Ingredient Alteration (PIA)
16.3.2. Drug Shortage Manufacturing
16.3.3. Pharmaceutical Dosage Alteration (PDA)
16.4. Market Value Forecast By Sterility, 2020-2034
16.4.1. Sterile
16.4.2. Non-sterile
16.5. Market Value Forecast By Dosage Form, 2020-2034
16.5.1. Oral Medications
16.5.1.1. Capsules
16.5.1.2. Tablets
16.5.1.3. Suspensions
16.5.1.4. Others (Chewables, etc.)
16.5.2. Topical Medications
16.5.2.1. Creams
16.5.2.2. Gels
16.5.2.3. Ointments
16.5.2.4. Others (Paste, etc.)
16.5.3. Injectables
16.5.4. Suppositories
16.5.5. Others
16.6. Market Value Forecast By Application, 2020-2034
16.6.1. Hormone Replacement Therapy
16.6.2. Pain Management
16.6.3. Neurology
16.6.4. Dermatology
16.6.5. Ophthalmology
16.6.6. Nutritional Supplements
16.6.7. Others (ENT, Thyroid Disorders, etc.)
16.7. Market Value Forecast By Patient Demographics, 2020-2034
16.7.1. Human
16.7.1.1. Pediatric
16.7.1.2. Adult
16.7.1.3. Geriatric
16.7.2. Veterinary
16.8. Market Value Forecast By Country/Sub-region, 2020-2034
16.8.1. Brazil
16.8.2. Mexico
16.8.3. Rest of Latin America
16.9. Market Attractiveness Analysis
16.9.1. By Pharmacy Type
16.9.2. By Compounding Type
16.9.3. By Sterility
16.9.4. By Dosage Form
16.9.5. By Application
16.9.6. By Patient Demographics
16.9.7. By Country/Sub-region
17. Middle East & Africa Compounding Pharmacy Market Analysis and Forecast
17.1. Introduction
17.1.1. Key Findings
17.2. Market Value Forecast By Pharmacy Type, 2020-2034
17.2.1. 503A Pharmacies
17.2.2. 503B Pharmacies
17.3. Market Value Forecast By Compounding Type, 2020-2034
17.3.1. Pharmaceutical Ingredient Alteration (PIA)
17.3.2. Drug Shortage Manufacturing
17.3.3. Pharmaceutical Dosage Alteration (PDA)
17.4. Market Value Forecast By Sterility, 2020-2034
17.4.1. Sterile
17.4.2. Non-sterile
17.5. Market Value Forecast By Dosage Form, 2020-2034
17.5.1. Oral Medications
17.5.1.1. Capsules
17.5.1.2. Tablets
17.5.1.3. Suspensions
17.5.1.4. Others (Chewables, etc.)
17.5.2. Topical Medications
17.5.2.1. Creams
17.5.2.2. Gels
17.5.2.3. Ointments
17.5.2.4. Others (Paste, etc.)
17.5.3. Injectables
17.5.4. Suppositories
17.5.5. Others
17.6. Market Value Forecast By Application, 2020-2034
17.6.1. Hormone Replacement Therapy
17.6.2. Pain Management
17.6.3. Neurology
17.6.4. Dermatology
17.6.5. Ophthalmology
17.6.6. Nutritional Supplements
17.6.7. Others (ENT, Thyroid Disorders, etc.)
17.7. Market Value Forecast By Patient Demographics, 2020-2034
17.7.1. Human
17.7.1.1. Pediatric
17.7.1.2. Adult
17.7.1.3. Geriatric
17.7.2. Veterinary
17.8. Market Value Forecast By Country/Sub-region, 2020-2034
17.8.1. GCC Countries
17.8.2. South Africa
17.8.3. Rest of Middle East & Africa
17.9. Market Attractiveness Analysis
17.9.1. By Pharmacy Type
17.9.2. By Compounding Type
17.9.3. By Sterility
17.9.4. By Dosage Form
17.9.5. By Application
17.9.6. By Patient Demographics
17.9.7. By Country/Sub-region
18. Competition Landscape
18.1. Market Player - Competition Matrix (By Tier and Size of companies)
18.2. Market Share Analysis By Company (2023)
18.3. Company Profiles
18.3.1. B. Braun SE
18.3.1.1. Company Overview
18.3.1.2. Financial Overview
18.3.1.3. Financial Overview
18.3.1.4. Business Strategies
18.3.1.5. Recent Developments
18.3.2. WEDGEWOOD PHARMACY
18.3.2.1. Company Overview
18.3.2.2. Financial Overview
18.3.2.3. Financial Overview
18.3.2.4. Business Strategies
18.3.2.5. Recent Developments
18.3.3. Fagron
18.3.3.1. Company Overview
18.3.3.2. Financial Overview
18.3.3.3. Financial Overview
18.3.3.4. Business Strategies
18.3.3.5. Recent Developments
18.3.4. Fresenius Kabi AG
18.3.4.1. Company Overview
18.3.4.2. Financial Overview
18.3.4.3. Financial Overview
18.3.4.4. Business Strategies
18.3.4.5. Recent Developments
18.3.5. Avella Specialty Pharmacy
18.3.5.1. Company Overview
18.3.5.2. Financial Overview
18.3.5.3. Financial Overview
18.3.5.4. Business Strategies
18.3.5.5. Recent Developments
18.3.6. Aurora Health Care
18.3.6.1. Company Overview
18.3.6.2. Financial Overview
18.3.6.3. Financial Overview
18.3.6.4. Business Strategies
18.3.6.5. Recent Developments
18.3.7. Walgreen Co.
18.3.7.1. Company Overview
18.3.7.2. Financial Overview
18.3.7.3. Financial Overview
18.3.7.4. Business Strategies
18.3.7.5. Recent Developments
18.3.8. Formul8
18.3.8.1. Company Overview
18.3.8.2. Financial Overview
18.3.8.3. Financial Overview
18.3.8.4. Business Strategies
18.3.8.5. Recent Developments
18.3.9. Triangle Compounding
18.3.9.1. Company Overview
18.3.9.2. Financial Overview
18.3.9.3. Financial Overview
18.3.9.4. Business Strategies
18.3.9.5. Recent Developments
18.3.10. Apollo Clinical Pharmacy
18.3.10.1. Company Overview
18.3.10.2. Financial Overview
18.3.10.3. Financial Overview
18.3.10.4. Business Strategies
18.3.10.5. Recent Developments
18.3.11. The London Specialist Pharmacy Ltd
18.3.11.1. Company Overview
18.3.11.2. Financial Overview
18.3.11.3. Financial Overview
18.3.11.4. Business Strategies
18.3.11.5. Recent Developments
18.3.12. Olympia Pharmacy
18.3.12.1. Company Overview
18.3.12.2. Financial Overview
18.3.12.3. Financial Overview
18.3.12.4. Business Strategies
18.3.12.5. Recent Developments
18.3.13. Fusion Apothecary
18.3.13.1. Company Overview
18.3.13.2. Financial Overview
18.3.13.3. Financial Overview
18.3.13.4. Business Strategies
18.3.13.5. Recent Developments
18.3.14. Albertsons Companies, Inc.
18.3.14.1. Company Overview
18.3.14.2. Financial Overview
18.3.14.3. Financial Overview
18.3.14.4. Business Strategies
18.3.14.5. Recent Developments
18.3.15. JL Diekman and AQ Touchard
18.3.15.1. Company Overview
18.3.15.2. Financial Overview
18.3.15.3. Financial Overview
18.3.15.4. Business Strategies
18.3.15.5. Recent Developments
18.3.16. Roseway Labs
18.3.16.1. Company Overview
18.3.16.2. Financial Overview
18.3.16.3. Financial Overview
18.3.16.4. Business Strategies
18.3.16.5. Recent Developments
18.3.17. Hill’s Compounding Pharmacy and Milford Pharmacy
18.3.17.1. Company Overview
18.3.17.2. Financial Overview
18.3.17.3. Financial Overview
18.3.17.4. Business Strategies
18.3.17.5. Recent Developments
18.3.18. Other Prominent Players
18.3.18.1. Company Overview
18.3.18.2. Financial Overview
18.3.18.3. Financial Overview
18.3.18.4. Business Strategies
18.3.18.5. Recent Developments

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings